|
|||||
|
|
A phase II trial of ganetespib,a heat shock protein 90 Hsp90) inhibitor,in patients with docetaxel-pretreated metastatic castrate-resistant prostate cancer (CRPC)-a prostate cancer clinical trials consortium (PCCTC) study |
|
| Authors: | Manish K. Thakur Lance K. Heilbrun Shijie Sheng Mark Stein Glenn Liu Emmanuel S. Antonarakis Ulka Vaishampayan Sijana H. Dzinic Xiaohua Li Stacy Freeman Daryn Smith Elisabeth I. Heath |
| Affiliation: | 1.Karmanos Cancer Institute,Wayne State University,Detroit,USA;2.Rutgers Cancer Institute of New Jersey,New Brunswick,USA;3.University of Wisconsin Carbone Cancer Center,University of Wisconsin-Madison,Madison,USA;4.Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Baltimore,USA |
| Abstract: | |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |